Valuation: DexCom, Inc.

Market Cap 31.47B 27.93B 26.14B 23.69B 44.75B 3,033B 45.07B 314B 122B 1,548B 118B 116B 4,975B P/E 2026 *
33.5x
P/E 2027 * 28.2x
Enterprise Value 30.71B 27.26B 25.51B 23.12B 43.67B 2,960B 43.98B 306B 119B 1,510B 115B 113B 4,855B EV / Sales 2026 *
5.87x
EV / Sales 2027 * 5.24x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-4.04%
1 week-3.75%
Current month-3.36%
1 month-5.13%
3 months+15.21%
6 months+31.93%
Current year+25.64%
1 week 82.86
Extreme 82.86
87.7
1 month 82.29
Extreme 82.29
90.38
Current year 56.72
Extreme 56.72
92.59
1 year 54.11
Extreme 54.11
92.59
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Date Insider Type Main position Quantity % Market Cap. Importance
28/9/26 Sell

Head of Human Resources

-2,565 0.0007%
15/9/26 Sell

Compliance Officer

-1,700 0.0005%
15/9/26 Sell

Director

-6,539 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-4.04%-3.75%+25.66%+0.20% 31.47B
-1.94%-2.76%-26.60%+1.32% 170B
-1.00%0.00%-11.52%+14.41% 111B
-2.46%-0.20%-24.05%+4.65% 107B
+0.07%+0.82%-46.89%-10.10% 75.95B
+0.46%+2.85%+3.63%+72.08% 60.37B
-0.65%+6.59%+11.44%+66.40% 53.53B
-0.20%-0.92%-6.09%-31.29% 49.11B
-2.21%-3.38%-17.90%+15.57% 40.6B
-0.70%+1.63% - - 31.19B
Average -1.27%+0.38%-10.26%+14.80% 73.02B
Weighted average by Cap. -1.31%+0.03%-16.19%+12.25%

Financials

2026 *2027 *
Net sales 5.23B 4.64B 4.34B 3.94B 7.44B 504B 7.49B 52.18B 20.3B 257B 19.63B 19.21B 827B 5.8B 5.15B 4.82B 4.37B 8.25B 559B 8.31B 57.87B 22.51B 285B 21.77B 21.3B 917B
Net income 974M 865M 809M 734M 1.39B 93.93B 1.4B 9.72B 3.78B 47.92B 3.66B 3.58B 154B 1.15B 1.02B 954M 865M 1.63B 111B 1.65B 11.46B 4.46B 56.5B 4.31B 4.22B 182B
Net Debt -761M -676M -632M -573M -1.08B -73.37B -1.09B -7.59B -2.95B -37.43B -2.86B -2.8B -120B -1.06B -942M -882M -799M -1.51B -102B -1.52B -10.59B -4.12B -52.2B -3.98B -3.9B -168B
Projected Income Statement - Annual - DexCom, Inc.
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
06/10/26 USD 83.39 -4.04% 3,574,805
05/10/26 USD 86.90 +1.80% 3,079,140
02/10/26 USD 85.36 -1.01% 2,204,390
01/10/26 USD 86.23 -0.07% 3,034,749
30/09/26 USD 86.29 -0.40% 3,474,452
Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - DexCom, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
83.39USD
Average target price
96.23USD
Spread / Average Target
+15.40%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DexCom, Inc.
  1. Stock Market
  2. Stocks
  3. DXCM Stock